Presenting Companies at the 19th Annual Future Leaders in the Biotech Industry
Wednesday, March 14, 2012 at 11:29AM
DDE Editor in Conferences
Future Leaders in the Biotech Industry returns for its 19th meeting with a slate of companies positioned to meet the investment criteria that the current market demands.

The conference is organized by BioCentury & Thomson Reuters, with the Special Support of GOLD SPONSOR Rodman & Renshaw.
Contributing Sponsors: AstraZeneca, 
Ladenburg Thalmann, MLV & Co., OrbiMed Advisors, WBB Securities, and Yorkville Advisors. 
PRE-REGISTER NOW TO RESERVE YOUR SEAT!

The Future Leaders Class of 2012 will showcase companies with a solid mix of innovative science and platform assets, plus later stage compounds with near-term commercial milestones. Features for this year’s slate include a track of epigenetics plays, fresh IPO stories, mature privates readying for IPO, companies with upcoming Phase III data sets and selected international companies with key value inflection points. 
The Presenting Companies are as follows:

For more information about the conference and the presenting companies, please go to www.biocentury.com/conferences and click "BioCentury Events." 

Article originally appeared on Daily Dose Equities - Wall Street Analysis for Biomedical Research (http://dailydoseequities.filmannex.com/).
See website for complete article licensing information.